Immunis Inc

Immunis Inc. is a privately held biotechnology company based in Irvine, California. The company employs 9 people and generated $2.5 million in revenue. Immunis focuses on developing treatments for age-related and disease-related immune deficiencies. Their technology centers around growing human cells for clinical use and directing them to produce factors that promote immune system development, modulation, and overall health. They aim to address the natural decline of these beneficial factors that occurs with aging. Immunis' investigational product is an all-natural, all-human solution that provides a balanced set of immune modulators at naturally occurring concentrations. Their initial clinical trial is a Phase 1/2a study exploring the effectiveness of their product, STEM, in treating muscle atrophy, a condition common with age. For more information, visit immunisbiomedical.com.